HER-2 Negative Breast Cancer Treatment Is Estimated To Witness High Growth Owing To Increasing Research And Development Activities
HER-2 negative breast cancer refers to breast cancer that does not have excess amounts of the human epidermal growth factor receptor 2 (HER2) protein. HER2-targeted therapies work well for HER2-positive cancers, but new treatment options are still needed for HER2-negative disease, which accounts for around 70% of all breast cancer cases. The HER-2 negative breast cancer treatment market has...
0 Comentários 0 Compartilhamentos 660 Visualizações 0 Anterior
Patrocinado